GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » Cyclically Adjusted Revenue per Share

Genomma Lab InternacionalB de CV (MEX:LABB) Cyclically Adjusted Revenue per Share : MXN17.19 (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Genomma Lab InternacionalB de CV's adjusted revenue per share for the three months ended in Dec. 2024 was MXN4.772. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN17.19 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Genomma Lab InternacionalB de CV's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Genomma Lab InternacionalB de CV was 9.10% per year. The lowest was 6.00% per year. And the median was 8.45% per year.

As of today (2025-05-10), Genomma Lab InternacionalB de CV's current stock price is MXN21.38. Genomma Lab InternacionalB de CV's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was MXN17.19. Genomma Lab InternacionalB de CV's Cyclically Adjusted PS Ratio of today is 1.24.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Genomma Lab InternacionalB de CV was 1.86. The lowest was 0.76. And the median was 1.39.


Genomma Lab InternacionalB de CV Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Cyclically Adjusted Revenue per Share Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.09 14.45 15.86 16.56 17.19

Genomma Lab InternacionalB de CV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.56 16.84 16.96 17.14 17.19

Competitive Comparison of Genomma Lab InternacionalB de CV's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Cyclically Adjusted PS Ratio falls into.


;
;

Genomma Lab InternacionalB de CV Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genomma Lab InternacionalB de CV's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=4.772/155.1579*155.1579
=4.772

Current CPI (Dec. 2024) = 155.1579.

Genomma Lab InternacionalB de CV Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 2.608 99.973 4.048
201506 2.819 99.382 4.401
201509 2.566 100.112 3.977
201512 2.587 101.588 3.951
201603 2.727 102.573 4.125
201606 2.706 101.905 4.120
201609 2.787 103.084 4.195
201612 3.031 105.002 4.479
201703 3.054 108.063 4.385
201706 2.775 108.339 3.974
201709 2.936 109.628 4.155
201712 2.751 112.114 3.807
201803 2.873 113.505 3.927
201806 2.791 113.373 3.820
201809 2.610 115.130 3.517
201812 3.070 117.530 4.053
201903 2.994 118.050 3.935
201906 3.127 117.848 4.117
201909 3.024 118.581 3.957
201912 3.164 120.854 4.062
202003 3.276 121.885 4.170
202006 3.573 121.777 4.552
202009 3.368 123.341 4.237
202012 3.411 124.661 4.245
202103 3.486 127.574 4.240
202106 3.798 128.936 4.570
202109 3.970 130.742 4.711
202112 4.076 133.830 4.726
202203 4.001 137.082 4.529
202206 4.309 139.233 4.802
202209 4.509 142.116 4.923
202212 4.284 144.291 4.607
202303 3.968 146.472 4.203
202306 4.531 146.272 4.806
202309 4.267 148.446 4.460
202312 3.718 151.017 3.820
202403 4.427 152.947 4.491
202406 4.906 153.551 4.957
202409 5.092 155.158 5.092
202412 4.772 155.158 4.772

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Genomma Lab InternacionalB de CV  (MEX:LABB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Genomma Lab InternacionalB de CV's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=21.38/17.19
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Genomma Lab InternacionalB de CV was 1.86. The lowest was 0.76. And the median was 1.39.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Genomma Lab InternacionalB de CV Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines